graphic
Markets & Stocks
Street Talk: DuPont cut
September 8, 2000: 11:06 a.m. ET

PaineWebber cuts DuPont's price target; National Semiconductor praised
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Citing more potential earnings disappointments, PaineWebber slashed its price target for DuPont's stock Friday.

PaineWebber lowered the target on the largest U.S. chemical company

to $55 from $70, saying if the company's management does not meet its looser earnings guidance the stock could plummet to mid-$30 levels. 

On Thursday, DuPont (DD: Research, Estimates) said that higher-than-anticipated energy and raw material costs would cause it to miss full-year earnings estimates.

Shares of the Dow component fell $1 to $41.13 in midmorning trading.

Chips still in focus


The chip sector remained under scrutiny with National Semiconductor (NSM: Research, Estimates) receiving praise from a number of analysts after it reported better-than-expected fiscal first-quarter earnings Thursday.

Bear Stearns said the stock was "dramatically undervalued" and maintained its "buy" rating.

But Donaldson Lufkin & Jenrette kept a cautious stance on SpeedFam-IPEC (SFAM: Research, Estimates).

The maker of semiconductor manufacturing equipment warned late Thursday it expects to report a first-quarter operating loss of about 23 cents to 27 cents a share due to a delay of tool delivery. Analysts surveyed by First Call were expecting earnings of 12 cents a share.

DLJ reiterated its "market perform" rating on the stock, adding the shortfall was a "company specific" issue and does not reflect an impending downturn for the entire semiconductor industry.

Earlier this week, chip makers Intel (INTC: Research, Estimates) and

Micron Technology (MU: Research, Estimates) saw their ratings slashed by Wall Street analysts.

More 'buys'


In other ratings updates, Credit Suisse First Boston kept "buy" ratings on Internet investment firm CMGI (CMGI: Research, Estimates) and telecom leader Motorola (MOT: Research, Estimates).

And Lehman Brothers raised its 12-month price target on health care services provider McKesson HBOC (MCK: Research, Estimates) to $34 from $30 and also reiterated a "buy" rating.

Shares of McKesson rose 81 cents to $26.25. Back to top

  RELATED SITES

Latest upgrades

Latest downgrades

Initiated coverage

Stock split calendar

IPO's

Earnings warnings

Economic calendar

View the latest market update via Netshow

See how your mutual funds are doing

Need investing advice? Try Quicken.com on fn

Track your stocks

U.S. stock markets

Widely held stocks


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.